Opus Medical

Opus Medical Therapies is an innovative medical device company focused on the development of transcatheter solutions for structural heart diseases, specifically targeting mitral and tricuspid valve regurgitation. The company's core technology is a novel, fully percutaneous ventricular anchoring platform designed to simulate traditional surgical trans-apical anchoring without the need for invasive apical access. This modular platform enables a variety of structural heart applications, including valve replacement, annuloplasty, and chordal repair. Through a strategic partnership with Venus Medtech, Opus Medical Therapies is advancing its Transcatheter Mitral Valve Replacement (TMVR) and Transcatheter Tricuspid Valve Replacement (TTVR) systems toward global commercialization, with a significant focus on the Greater China market.